---
title: "Ellomay Enters the Italian Battery Storage Market with the Execution of an Agreement to Acquire a 51.75 MW / 207 MWh (4-hour) Project in Northern Italy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294110090.md"
description: "Ellomay Capital Ltd. announced the acquisition of a 51.75 MW / 207 MWh battery energy storage project in northern Italy via its Luxembourg subsidiary. This deal marks Ellomay's entry into the Italian electricity storage market and expands its renewable energy portfolio across Europe, the USA, and Israel."
datetime: "2026-07-28T20:12:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294110090.md)
  - [en](https://longbridge.com/en/news/294110090.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294110090.md)
generator: "portal-rs"
---

# Ellomay Enters the Italian Battery Storage Market with the Execution of an Agreement to Acquire a 51.75 MW / 207 MWh (4-hour) Project in Northern Italy

Today in Tel-Aviv, Israel, Ellomay Capital Ltd. revealed that its Luxembourg subsidiary has agreed to purchase a project company owning a 51.75 MW / 207 MWh battery energy storage system in northern Italy. This marks Ellomay's initial venture into the Italian electricity storage market. The project is set for development and is expected to provide significant renewable energy to the region. Ellomay, known for its renewable energy projects across Europe, USA, and Israel, continues to expand its portfolio with this acquisition.

### Related Stocks

- [ELLO.US](https://longbridge.com/en/quote/ELLO.US.md)

## Related News & Research

- [Ellomay affiliate Ellomay Solar Italy Fifteen connects 10 MW Piemonte solar plant to Italian grid](https://longbridge.com/en/news/294675814.md)
- [nVent to Acquire Maverick Power | NVT Stock News](https://longbridge.com/en/news/296774192.md)
- [Workday stock is downgraded after buyout report as growth expectations are 'too optimistic'](https://longbridge.com/en/news/296104750.md)
- [MSH Capital Advisors LLC Acquires New Shares in Chevron Corporation $CVX](https://longbridge.com/en/news/296598647.md)
- [BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment](https://longbridge.com/en/news/296376333.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**